The increasing demand for precise immunological investigation and therapeutic design has spurred significant advances in recombinant cytokine production. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently manufactured using multiple expression methods, including bacterial hosts, mammalian cell cultures, and viral